Yi Chi Song

Yi Chi Song is an Associate at Casdin Capital, LLC, specializing in biotech since August 2023, following a tenure as a Biotech Equity Research Associate at Jefferies from August 2021 to July 2023, where reported to Lead Analyst Michael Yee. Prior experience includes serving as an Analyst at Back Bay Life Science Advisors, a Business Development Intern at MedRhythms, Inc., and a Summer Analyst at Cornerstone Research. Yi Chi Song began an academic career as an Undergraduate Research Assistant in the Kumar Lab at Tufts University while pursuing a Bachelor of Science degree in Biochemistry, graduating summa cum laude in 2020, after attending Dulwich College Beijing and earning an IB Diploma.